BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Seegene's High Multiplex PCR Assay Capable of Detecting New Omicron Variant

Seegene Inc. (KQ 096530), South Korea's leading molecular diagnostics company, today confirmed that its Allplex™ SARS-CoV-2 Master Assay i...

December 01, 2021 | News

Thermo Fisher Scientific Confirms Detection of Omicron Variant with its TaqPath COVID-19 Tests

The Omicron variant, which was designated a "variant of concern" by the World Health Organization (WHO), has more than 30 mutations in the spike protein al...

November 30, 2021 | News

Merck Survey: "Europeans' perception of health two years after the start of Covid 19"

The study "Merck Survey: "Europeans' perception of health two years after the start of Covid 19" was conducted in 10 European countries Almost...

November 26, 2021 | News

Novavax Files for Interim Authorization of COVID-19 Vaccine in Singapore

"Today's filing reinforces our ongoing commitment to delivering our COVID-19 vaccine, built on a proven, well-understood vaccine platform, to help end the ...

November 25, 2021 | News

Singapore Brand Buzud Launches Patented Oxygen Concentrator

A grand opening event was held yesterday at the retail store. Gracing the occasion with his presence was Dr Loo Choon Yong, executive chairman of Raffles M...

November 24, 2021 | News

Laos becomes the 20th country to authorize the one-shot Sputnik Light vaccine

Sputnik Light vaccine is based on human adenovirus serotype 26, which is the first component of the Sputnik V vaccine. In March 2021 the two-dose...

November 24, 2021 | News

How to Navigate Senior Care with added COVID Cautions

As if navigating senior care wasn't difficult enough, families around the world carry the weight of each decision they make for their loved one with the ad...

November 18, 2021 | Opinion

Novavax Announces Submission of Biologics License Application in South Korea for Approval of NVX-CoV2373

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious dise...

November 23, 2021 | News

Merck and Ridgeback Announce Japanese Government to Purchase 1.6 Million Courses of Molnupiravir

Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced that the Japanese government will purch...

November 11, 2021 | News

Molnupiravir, an Oral COVID-19 Antiviral Medicine, Receives First Authorization in the World

Applications Remain Under Review by Other Regulatory Authorities, Including U.S. Food and Drug Administration and the European Medicines Agency Merck (NYS...

November 08, 2021 | News

Novavax Files COVID-19 Vaccine for EU Listing with WHO

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious dise...

November 05, 2021 | News

Novavax Files COVID-19 Vaccine for Provisional Approval in New Zealand

All modules required for regulatory review of Novavax vaccine, including CMC data, are now complete for Medsafe Novavax, Inc. (Nasdaq: NVAX), a biote...

November 04, 2021 | News

Novavax and Serum Institute of India Receive EUA for COVID-19 Vaccine in Indonesia

"The first authorization of Novavax' COVID-19 vaccine exemplifies our commitment to equitable global access and will fill a vital need for Indonesia, ...

November 02, 2021 | News

Novavax Files for Provisional Approval of its COVID-19 Vaccine in Australia

-- Application marks the first protein-based COVID-19 vaccine submitted to regulatory authorities for provisional approval in Australia --...

November 01, 2021 | News

Stay Connected